Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and Cicatrix

gefitinib has been researched along with Cicatrix in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, PC; Chu, CY; Shih, YH1
Donovan, JC; Ghazarian, DM; Shaw, JC1

Other Studies

2 other study(ies) available for gefitinib and Cicatrix

ArticleYear
Severe refractory scarring alopecia associated with combinational use of ficlatuzumab (AV-299) and gefitinib.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-10, Volume: 31, Issue:20

    Topics: Aged; Alopecia; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cicatrix; Female; Follow-Up Studies; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Quinazolines; Risk Assessment; Severity of Illness Index

2013
Scarring alopecia associated with use of the epidermal growth factor receptor inhibitor gefitinib.
    Archives of dermatology, 2008, Volume: 144, Issue:11

    Topics: Aged; Alopecia; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Cicatrix; Disease Progression; ErbB Receptors; Fatal Outcome; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Male; Quinazolines; Risk Assessment

2008